CD276 (B7H3) improve cancer stem cells formation in cervical carcinoma cell lines

BACKGROUND: Cancer stem cells (CSCs) have been considered as a potential therapeutic target for cervical carcinoma. CD 276 is a well-known immune check point molecular, but its relationship with cervical CSCs was still unclear. METHODS: HeLa cell lines were obtained as cervical carcinoma in vitro mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jianfeng, Zhao, Haishan, Lian, Huan, Ke, Linnan, Zhao, Lei, Wang, Chunren, Han, Qianqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798926/
https://www.ncbi.nlm.nih.gov/pubmed/35116240
http://dx.doi.org/10.21037/tcr-19-2910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798926/
https://www.ncbi.nlm.nih.gov/pubmed/35116240
http://dx.doi.org/10.21037/tcr-19-2910

Ejemplares similares